We first assessed the levels of phosphorylated/inactive GSK3β in peripheral lung tissue, peripheral blood monocytes and PBECs from COPD patients, nonsmokers and smokers with normal lung function. This evidence concerns the gene GSK3B and chronic obstructive pulmonary disease.